Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Hypoxia-Induced Osteopontin-Positive Glioma-Associated Macrophages Facilitate Glioma Mesenchymal Transition via NF-κB Pathway Activation.
PMID 41625475 · PMC12857759 · Cancer communications (London, England) · 2026 · 6 claims · 8 setups
A subset of GAMs with elevated OPN expression accumulates in response to hypoxic stimulation
-
Full-text index only
Multi-omics analyses related to unfolded protein response in prostate cancer implicate pro-tumor role of IFRD1.
PMID 41694360 · PMC12894258 · Frontiers in immunology · 2026 · 8 claims · 8 setups
Luminal prostate epithelial cells, especially the LE-KLK3 subpopulation, show elevated UPR activity compared to other cell types
-
Full-text index only
Multi-omics analyses related to mitochondria and ageing in triple-negative breast cancer implicate PYCR1 potentiates tumor progression.
PMID 41749247 · PMC13041056 · Cancer cell international · 2026 · 8 claims · 8 setups
A 4-gene mitochondrial ageing-related risk score (MARS) model (PYCR1, MAPT, CEBPA, BCL2A1) predicts TNBC prognosis
-
Full-text index only
Ectopic CD11c Drives SMAD3-Mediated Aberrant Antigen Presentation and Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma.
PMID 41799568 · PMC12963642 · Cancer communications (London, England) · 2026 · 8 claims · 13 setups
An ESCC epithelial cell subcluster with ectopic CD11c (ITGAX) expression, found in both mice and humans, exhibits concurrent impaired antigen presentation and EMT phenotypes
-
Full-text index only
AJUBA: The Master Regulator Bridging EMT and Immune Evasion in Colorectal Cancer.
PMID 41814682 · PMC13140425 · Mediators of inflammation · 2026 · 8 claims · 8 setups
AJUBA is markedly upregulated in CRC across multiple transcriptomic cohorts and is enriched in epithelial cells with activated EMT features
-
Full-text index only
Dissecting the immunosuppressive microenvironment of LAMA3 + malignant cells and SPP1 + macrophages in esophageal squamous cell carcinoma using single-cell and spatial transcriptomics.
PMID 41845425 · PMC13104401 · Journal of translational medicine · 2026 · 8 claims · 8 setups
A LAMA3+ epithelial subpopulation (C3) enriched at the invasive tumor front shows strong EMT signatures and is associated with poor prognosis
-
Full-text index only
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival.
PMID 41849608 · PMC12998525 · Science advances · 2026 · 8 claims · 8 setups
KLF5 binds subtype-independent highly interactive enhancers in PDAC that interact with essential genes
-
Full-text index only
Single-cell mitophagy signature-based artificial intelligence model enhances prediction of prognosis and immunotherapy response in non-small-cell lung cancer.
PMID 41851738 · PMC13112628 · Respiratory research · 2026 · 8 claims · 8 setups
A six-gene MRG panel (FOS, CANX, EIF4G1, CALCOCO2, HSP90AB1, PRKAR1A) was selected via LASSO regression as prognostic markers in NSCLC.
-
Full-text index only
Targeting TPX2-dependent lineage plasticity by CDK4/6 inhibition reverses therapy resistance in neuroendocrine bladder carcinoma.
PMID 41923619 · PMC13130694 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
A 315-gene 'NE-like signature' (NE-like Sig), derived from the WGCNA MEmidnightblue module, marks a lineage-plasticity-associated transcriptional program distinct from canonical NE differentiation.
-
Full-text index only
BCG-trained macrophages promote pan-anti-tumor activity through epigenetic rewiring of NOX2-ROS axis.
PMID 42032669 · PMC13261971 · Journal of experimental & clinical cancer research : CR · 2026 · 7 claims · 8 setups
BCG training induces pan-anti-tumor activity across multiple mouse tumor models, mediated predominantly by tumor-associated macrophages (TAMs)